ArticleMaedica2025
Analysis of Fatty Liver Prevalence in Non-Obese Women Diagnosed with Polycystic Ovary Syndrome.
Article in Maedica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Polycystic ovary syndrome (PCOS) has various causes that are largely unknown. The present study was aimed to evaluate metabolic and biochemical markers as well as body mass index (BMI) related to PCOS among two groups including patients and healthy controls. Methods: A case-control study included women younger than 45 years who did not suffer from obesity. Women with male-factor infertility served as the control group, while patients detected with PCOS via the Rotterdam criteria made up the case group. There were 86 randomly selected participants in each group. Fasting blood sugar (FBS), lipid profiles, alanine aminotransferase (ALT) and other biochemical tests were gathered with demographic data, medical records, physical exams and anthropometric measurements. Ultrasound, liver enzyme levels and medical history were utilized to diagnose non-alcoholic fatty liver disease (NAFLD). Results: About 172 women were selected for the research; 86 had PCOS, while the remaining 86 were healthy controls. A younger mean age and a higher BMI were found in women with PCOS. The findings showed that mild to moderate fatty liver was more prevalent in the PCOS group than the control one (P = 0.04). Although metabolic indices, liver enzymes, hematologic parameters and hormone levels did not alter significantly, the PCOS group had lower fasting blood sugar levels (P = 0.029). The correlation between total cholesterol and PCOS was still poor after adjusting for age in logistic regression analysis. Still, it became statistically insignificant after adjusting for BMI index. Conclusion: Non-obese women with PCOS had a higher prevalence of fatty liver, with minor differences in metabolic parameters, and BMI partly mediated these associations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.